Clinical Research Of Tianlong Tongluo Capsule Treatment To Ischemic Stroke In Wind Phlegm-blood Stasis Syndrome

Objective:By comparing patients with neurologic impairment,aspects,activities of daily living scale score,TCM syndrome score and blood lipids,blood rheology,etc.After the change before and after drug treatment,observation of "Xifeng expectorant,blood circulation" as medication guidelines related to drug treatment of stroke(cerebral infarction)convalescent wind phlegm Syndrome clinical efficacy.method:General information: The collection lot from Hospital of Hubei Province,Hubei Province,People’s Hospital of cases,selected to meet the diagnostic criteria for cerebral infarction convalescence Western medicine,Chinese medicine meridian line with wind phlegm syndrome diagnosis and differentiation criteria of 60 cases,in signing the informed By consent,the volunteers participating in the clinical trial observation.General information on selected cases through statistical tests,the presence of comparable.Treatment Methods: A randomized,double-blind,placebo-controlled design method,randomly assigned to the observation group and the control group(30 cases),and at the same time were taking essentialmedicines aspirin enteric-coated tablets(0.1g a day),to be related to conventional and symptomatic treatment.Further observation group: oral Dragon Capsules,3 times a day,once five;control group: oral placebo Dragon Capsules,3 times a day,once5;course of 14 days,respectively,of the total clinical efficacy,NIHSS score,TCM symptom scores,activities of daily living(ADL)score,lipid and blood rheology scores as indicators of clinical efficacy evaluated.The blood,urine,liver and kidney function,blood coagulation as a full set of safety indicators,before and after the tests are done testing,adverse reactions were observed and recorded in detail in a timely manner.Statistical Methods: Statistical analysis was performed using SPSS17.0 statistical software,using Ridit level data analysis,count data using the x2 test or analysis of variance,measurement data using t test or rank sum test statistics.result:1.Comparison of baseline before treatment,general information through statistical tests,comparable.2.With respect to the observation group and the control group Efficacy mainly from the following aspects to compare,the total clinical efficacy,NIHSS score,TCM symptom scores,activities of daily living(ADL)score,lipid and blood rheology score results It shows the difference was statistically significant,(P <0.05).3.Safety Evaluation Blood statistical observation group before and after treatment,liver and kidney function,blood coagulation were no significant differences in adverse effects and patient discomfort and no symptoms,no significant deterioration and adverse consequences,the results show that security can be.in conclusion:Dragon Capsules combined with conventional Western medicine treatment of stroke(cerebral infarction)recovery(wind phlegm Syndrome)method than the simple application of the efficacy of Western medicine better.Dragon Capsules on Treatment of Cerebral Infarction in improving clinical efficacy,NIHSS score,TCM symptom scores,activities of daily living,blood lipids,blood rheology and other than the control group in improving the quality of life of stroke patients and reduce complications,reduce overall morbidity,we have to reduce the huge economic and psychological burden on families and society certain advantages,but the course of treatment for patients with liver and kidney function,blood clotting functions for statistical analysis,the difference was not statistically significant,no significant adverse reactions and side effects,the observation group showed improvement in stroke(cerebral infarction)convalescent safety and clinical efficacy was significantly better than the control group,the clinical advantages that can guide clinical practice.